Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kensuke Hori
Observed name:
K. Hori
Institution:
Kansai Rosai Hospital
Observed institutions:
Kurume University,
Hyogo Medical University,
Kansai Rosai Hospital
ORCID:
0000-0003-3146-4919
Observed ORCID:
0000-0003-3146-4919
OpenAlex ID:
A5076217373
Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer
2020
·
Aikou Okamoto
, Eiji Kondo
, et al.
·
Journal of Gynecologic Oncology
·
15
Novel Strategy for the Management of Cervical Multicystic Diseases
2023
·
Ai Yoshino
, Eiji Kobayashi
, et al.
·
Annals of Surgical Oncology
·
12
PDF
A case of retroperitoneal desmoid-type fibromatosis that involved the unilateral ureter after gynaecologic surgery
2018
·
Hitomi Ono
, Kensuke Hori
, et al.
·
International Journal of Surgery Case Reports
·
12
PDF
Efficacy of Olanzapine in Addition to Standard Triplet Antiemetic Therapy for Cisplatin-Based Chemotherapy: A Secondary Analysis of the J-FORCE Randomized Clinical Trial
2023
·
Masakazu Abe
, Takuhiro Yamaguchi
, et al.
·
JAMA Network Open
·
11
PDF
Effectiveness of intraperitoneal or intrapleural administration of triamcinolone acetonide for the control of malignant ascites and pleural effusion (Kansai Clinical Oncology Group-G1102 study)
2017
·
Kimihiko Ito
, Hiroshi Tsubamoto
, et al.
·
Journal of Cancer Research and Therapeutics
·
8
Metronomic chemotherapy using oral cyclophosphamide and bevacizumab for recurrent cervical cancer: A multi-institutional retrospective study
2022
·
Roze Isono-Taniguchi
, Mayako Goto
, et al.
·
Gynecologic Oncology Reports
·
7
PDF
Adjuvant Chemotherapy for Endometrial Cancer (ACE) trial: A randomized phase II study for advanced endometrial carcinoma
2022
·
Tomomi Egawa‐Takata
, Yutaka Ueda
, et al.
·
Cancer Science
·
7
PDF
AnArthrobacterspp. Bacteremia Leading to Fetal Death and Maternal Disseminated Intravascular Coagulation
2012
·
Naoya Shigeta
, Kimiaki Ozaki
, et al.
·
Fetal and Pediatric Pathology
·
7
Phase II study of gemcitabine, cisplatin, and bevacizumab for first recurrent and refractory ovarian clear cell carcinoma Kansai Clinical Oncology Group-G1601
2022
·
Kimihiko Ito
, Mio Nakagawa
, et al.
·
Anti-Cancer Drugs
·
6
Combination therapy of oral cyclophosphamide and bevacizumab for patients with recurrent ovarian and peritoneal cancer
2023
·
Mayako Goto
, Hiroshi Tsubamoto
, et al.
·
Medicine
·
5
Endometrioid adenocarcinoma originating simultaneously from endometrium, sites of adenomyosis and ovarian endometriosis: A case report and review of our cancer database
2017
·
Lena Tashima
, Kensuke Hori
, et al.
·
International Journal of Surgery Case Reports
·
5
PDF
Advanced ovarian cancer that resulted in death from intestinal perforation following tumor lysis syndrome: A case report
2022
·
Saki Kunimoto
, Lena Tashima
, et al.
·
International Journal of Surgery Case Reports
·
4
PDF
Hypovolaemic shock due to intra-abdominal haemorrhage from multiple uterine fibroids
2021
·
Erika Takaki
, Mayako Goto
, et al.
·
BMJ Case Reports
·
4
A phase II, open-labeled, single-arm study of dose-dense paclitaxel plus carboplatin in advanced or recurrent uterine endometrial cancer treatment: a KCOG-G1303, DOENCA trial
2021
·
Kensuke Hori
, Shin Nishio
, et al.
·
Journal of Gynecologic Oncology
·
4
Validation of the distress and impact thermometer and the changes of mood during the first 6 months of treatment in gynecological cancer patients: a Kansai Clinical Oncology Group (KCOG)-G1103 prospective study
2016
·
Y. Itani
, A. Arakawa
, et al.
·
Archives of Gynecology and Obstetrics
·
4
Phase I study on pegylated liposomal doxorubicin in combination with docetaxel for patients with platinum-resistant or partially platinum-sensitive epithelial ovarian cancer: The Kansai Clinical Oncology Group study
2018
·
Kensuke Hori
, Kimihiko Ito
, et al.
·
Journal of Cancer Research and Therapeutics
·
3
Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study
2024
·
Daisuke Aoki
, Tsutomu Tabata
, et al.
·
Journal of Gynecologic Oncology
·
2
PDF
Efficacy of olanzapine combined with the standard triplet antiemetic therapy for cisplatin-based chemotherapy: A sub-analysis of a randomized, double-blind, placebo-controlled trial (J-FORCE).
2021
·
Yukiyoshi Fujita
, Masakazu Abe
, et al.
·
Journal of Clinical Oncology
·
2
[Efficacy of Olaparib Treatment for Platinum-Sensitive Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancers].
2020
·
Tomohiko Takei
, Erika Takaki
, et al.
·
PubMed
·
2
Multiple metastases after laparoscopic surgery for early-stage endometrial cancer: A case report
2020
·
Saori Tsuji
, Kensuke Hori
, et al.
·
International Journal of Surgery Case Reports
·
2
PDF
[A Case of Bilateral Pneumothorax after Chemotherapy for Uterine Leiomyosarcoma with Multiple Lung Metastases].
2016
·
Junko Murakami
, Kensuke Hori
, et al.
·
PubMed
·
2
[Clinical Application of Gemcitabine plus Cisplatin plus Bevacizumab Combination Chemotherapy for Ovarian Clear Cell Carcinoma].
2021
·
Mio Nakagawa
, Kimihiko Ito
, et al.
·
PubMed
·
1
834P A phase II study of gemcitabine, cisplatin, and bevacizumab for first recurrent and refractory ovarian clear-cell carcinoma (KCOG-G1601 trial)
2020
·
K. Ito
, M. Nakagawa
, et al.
·
Annals of Oncology
·
1
PDF
A phase II, open labeled, single-arm study of dose-dense paclitaxel plus carboplatin in advanced or recurrent uterine corpus cancer: KCOGG1303 study.
2019
·
Kensuke Hori
, Shin Nishio
, et al.
·
Journal of Clinical Oncology
·
1
[A Retrospective Case Study of Combination Chemotherapy with Bevacizumab for Recurrent Ovarian Cancer].
2016
·
Kensuke Hori
, Tomohiko Tsuruta
, et al.
·
PubMed
·
1
Show more works
View as search
Works count:
40
Citation count:
130
H-index:
7
I10-index:
4
Year
Topic
Type
